Camilo Paredes
Physician Assistant · Dallas, TXNPI 1124342316
Payments from drug & device makers
Across 592 payments — averaging $14.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$1K
- GSK$613
- Lilly USA, LLC$557
- Amgen$532
- Esperion Therapeutics, Inc.$456
- plus $4K from 42 others
What the payments were for
- Food & beverage$8,518100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,519 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 62 | $85,490 |
| OzempicSemaglutide | 53 | $69,342 |
| FarxigaDapagliflozin Propanediol | 19 | $22,322 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $17,837 |
| Xigduo XrDapaglifloz Propaned/Metformin | 18 | $16,949 |
| PremarinEstrogens, Conjugated | 15 | $4,145 |
| Potassium Chloride | 51 | $2,108 |
| Rosuvastatin Calcium | 139 | $1,182 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,132 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 29 | $854 |
| Gabapentin | 55 | $804 |
| Testosterone Cypionate | 13 | $799 |
| Levothyroxine Sodium | 78 | $649 |
| Pioglitazone Hcl | 66 | $637 |
| Aripiprazole | 24 | $611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $557 | $85,49062 claims |
| Novo NordiskOzempic | $1,096 | $69,34253 claims |
| AstraZenecaFarxiga | $163 | $22,32219 claims |
| GSKTrelegy Ellipta | $613 | $17,83721 claims |
| PfizerPremarin | $170 | $4,14515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Dallas
- Cynthia TrickettDallas$1.3M
- Michael WhiteDallas$276K
- Sofia NeicherilDallas$62K
- Shawn SommerladDallas$53K
- Katherine TurnerDallas$43K
- Tori BurnsDallas$39K
- Suzanne RaczDallas$32K
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.